Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
This is fueled by the meteoric rise of GLP-1 agonist molecules leading to 2-digit weight loss and the new dual, triple and tetra agonist promising even higher weight reduction comparable to what it could be achieved in the past only by bariatric surgery
doi:10.1016/s2213-8587(24)00272-9 Sargeant, J
As of the time of writing, retatrutide is not licensed for use in the United Kingdom
There may still be limited use under 503A compounding rules, where a medication is prepared for an individual patient based on a specific clinical indication, but that pathway is much more restricted and not designed for widespread use. Jen Manne-Goehler, MD, ScD,assistant professor of medicine at Harvard Medical School, agreed
US$ 27.81
US$ 22.58
US$ 22.79
US$ 22.44
US$ 23.64
US$ 20.45
